System and method for detecting acute brain function impairment
A system and method is provided for acquiring data from a brain of a subject and analyzing the data to generate an indication of a level of acute impairment of the subject.
1. A system for determining an acute brain function impairment of a subject, the system comprising:
a sensor system configured to acquire signals indicative of a function of a brain of the subject, wherein the sensor system includes a first set of sensors configured to acquire the signals from the prefrontal cortex and a second set of sensors configured to acquire the signals from an area of the brain outside the prefrontal cortex;
a processor configured to receive the signals from the sensor system and configured to:
analyze the signals to determine an amount of functional connectivity between portions of the brain of the subject from the signals acquired from the first set of sensors and a reference amount of functional connectivity from the signals acquired from the second set of sensors;
compare the amount of functional connectivity between portions of the brain of the subject to the reference amount of functional connectivity;
determine acute physical and/or mental performance deficiencies caused by consumption of intoxicants of the subject based on the comparison of the amount of functional connectivity between portions of the brain of the subject to the reference amount of functional connectivity; and
generate a report indicating the acute physical and/or mental performance deficiencies of the subject.
2. The system of claim 1 , wherein the sensor system includes a plurality of near infrared spectroscopy (NIRS) sensors configured to acquire the signals.
3. The system of claim 2 , wherein the plurality of NIRS sensors includes eight sensors configured to be arranged along a forehead of the subject.
4. The system of claim 1 , further comprising a headband configured to arrange the sensor system to acquire the signals from the prefrontal cortex of the subject.
5. The system of claim 1 , further comprising a display configured to display the report.
6. The system of claim 1 , wherein the processor is configured to implement a machine learning architecture to perform at least one of the analyzing, comparing, and determining.
7. The system of claim 6 , wherein the machine learning architecture includes a random forest architecture trained on impairment data from subjects having been administered Δ9-tetrahydrocannabinol (THC).
8. The system of claim 1 , wherein the report includes a quantitative indication of the acute physical and/or mental performance deficiencies of the subject based on an increase in the amount of functional connectivity between portions of the brain of the subject compared to the reference amount of functional connectivity.
9. A method for detecting acute impairment, the method including steps comprising:
a) acquiring, with a sensor system, signals from a subject indicative of brain functionality of the subject, including acquiring the signals from the prefrontal cortex from a first set of sensors and acquiring the signals from an area of the brain outside the prefrontal cortex from a second set of sensors;
b) processing, using a computer processor, the signals to determine functional connectivity between portions of the brain of the subject from the signals acquired from the first set of sensors and a reference amount of functional connectivity from the signals acquired from the second set of sensors;
c) determining, using the computer processor, whether the functional connectivity of the brain of the subject is indicative of acute physical and/or mental performance deficiencies caused by consumption of intoxicants of the subject based on the comparison of the amount of functional connectivity between portions of the brain of the subject to the reference amount of functional connectivity; and
d) generating a report indicating the acute physical and/or mental performance deficiencies of the subject from the determining of step c).
10. The method of claim 9 , wherein step c) includes utilizing a machine learning model trained to analyze metabolizing of Δ9-tetrahydrocannabinol (THC) by the subject.
11. The method of claim 10 , wherein the machine learning model includes a Support Vector Machine regression (SVM-R) model.
12. The method of claim 10 , wherein the machine learning model includes a random forest model.
13. The method of claim 9 , wherein step b) includes determining an oxy-hemoglobin (HbO) concentration in the subject from the signals and determining the functional connectivity based on correlations between HbO concentration over time in the subject's brain.